These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 2070168

  • 1. Antiprogesterones.
    Norman J.
    Br J Hosp Med; 1991 Jun; 45(6):372-5. PubMed ID: 2070168
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mode of action of RU 486.
    Bygdeman M, Swahn ML, Gemzell-Danielsson K, Svalander P.
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [Abstract] [Full Text] [Related]

  • 4. Antigestogens.
    Baird DT.
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
    Papp C, Schatz F, Krikun G, Hausknecht V, Lockwood CJ.
    Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
    [Abstract] [Full Text] [Related]

  • 7. Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in women.
    Spitz IM, Shoupe D, Sitruk-Ware R, Mishell DR.
    J Reprod Fertil Suppl; 1989 Oct; 37():253-60. PubMed ID: 2681741
    [Abstract] [Full Text] [Related]

  • 8. The antiprogesterone steroid, RU 486 (mifepristone).
    Permezel M.
    Aust N Z J Obstet Gynaecol; 1990 Feb; 30(1):77-80. PubMed ID: 2189395
    [Abstract] [Full Text] [Related]

  • 9. Contraception by the progesterone antagonist RU 486: a novel approach to human fertility control.
    Baulieu EE.
    Res Reprod; 1987 Jan; 19(1):3-4. PubMed ID: 12314576
    [Abstract] [Full Text] [Related]

  • 10. Antiprogestogens: from abortion to contraception.
    Prog Hum Reprod Res; 1992 Jan; (22):6-7. PubMed ID: 12286013
    [Abstract] [Full Text] [Related]

  • 11. Fertility control in women: results with RU 486 by the end of 1985.
    Baulieu E.
    J Steroid Biochem; 1986 Nov; 25(5B):847-51. PubMed ID: 3807366
    [Abstract] [Full Text] [Related]

  • 12. [A new antiprogestational compound, mifepristone (RU-486)].
    Parisi C, Steffe M.
    Patol Clin Ostet Ginecol; 1988 Nov; 16(4):291-4. PubMed ID: 12345008
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Application of anti-progesterone agents for contraception].
    Taketani Y, Mizuno M.
    Rinsho Fujinka Sanka; 1988 Nov; 42(11):997-1000. PubMed ID: 12283954
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mifepristone (RU486): a review.
    Mahajan DK, London SN.
    Fertil Steril; 1997 Dec; 68(6):967-76. PubMed ID: 9418681
    [Abstract] [Full Text] [Related]

  • 19. Mifepristone: a potential contraceptive.
    Heikinheimo O, Archer DF.
    Clin Obstet Gynecol; 1996 Jun; 39(2):461-8. PubMed ID: 8734010
    [Abstract] [Full Text] [Related]

  • 20. [Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
    Gaillard RC, Herrmann W.
    Ann Endocrinol (Paris); 1983 Jun; 44(5):345-6. PubMed ID: 6675522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.